Justin Zelin
Stock Analyst
(3.03)
# 2,439
Out of 4,648 analysts
35
Total ratings
25.93%
Success rate
7.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Justin Zelin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDYA IDEAYA Biosciences | Maintains: Buy | $55 → $62 | $29.44 | +110.60% | 2 | Jul 9, 2024 | |
| JSPR Jasper Therapeutics | Initiates: Buy | $90 | $21.44 | +319.78% | 1 | Jul 8, 2024 | |
| TCRX TScan Therapeutics | Initiates: Buy | $12 | $5.02 | +139.04% | 1 | May 16, 2024 | |
| LYRA Lyra Therapeutics | Downgrades: Neutral | n/a | $0.26 | - | 2 | May 6, 2024 | |
| CARM Carisma Therapeutics | Initiates: Buy | $6 | $1.07 | +463.38% | 1 | Apr 11, 2024 | |
| VKTX Viking Therapeutics | Maintains: Buy | $100 → $125 | $66.81 | +87.10% | 4 | Mar 26, 2024 | |
| VSTM Verastem | Assumes: Buy | $27 | $3.94 | +585.28% | 1 | Nov 21, 2023 | |
| MBIO Mustang Bio | Maintains: Buy | $20 → $16 | $0.26 | +6,111.18% | 4 | Aug 15, 2023 | |
| IMCR Immunocore Holdings | Maintains: Buy | $85 → $91 | $31.40 | +189.81% | 2 | Aug 11, 2023 | |
| ACET Adicet Bio | Maintains: Buy | $20 → $10 | $1.26 | +693.65% | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $1.55 | +932.26% | 1 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $37 | $9.39 | +294.04% | 2 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $35 | $19.28 | +81.56% | 1 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $43.49 | +106.94% | 2 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $31 | $17.54 | +76.74% | 1 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $16 | $110.01 | -85.91% | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.09 | - | 3 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $10 | $5.86 | +70.65% | 3 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $2.56 | +1,465.56% | 1 | May 18, 2021 |
IDEAYA Biosciences
Jul 9, 2024
Maintains: Buy
Price Target: $55 → $62
Current: $29.44
Upside: +110.60%
Jasper Therapeutics
Jul 8, 2024
Initiates: Buy
Price Target: $90
Current: $21.44
Upside: +319.78%
TScan Therapeutics
May 16, 2024
Initiates: Buy
Price Target: $12
Current: $5.02
Upside: +139.04%
Lyra Therapeutics
May 6, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.26
Upside: -
Carisma Therapeutics
Apr 11, 2024
Initiates: Buy
Price Target: $6
Current: $1.07
Upside: +463.38%
Viking Therapeutics
Mar 26, 2024
Maintains: Buy
Price Target: $100 → $125
Current: $66.81
Upside: +87.10%
Verastem
Nov 21, 2023
Assumes: Buy
Price Target: $27
Current: $3.94
Upside: +585.28%
Mustang Bio
Aug 15, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $0.26
Upside: +6,111.18%
Immunocore Holdings
Aug 11, 2023
Maintains: Buy
Price Target: $85 → $91
Current: $31.40
Upside: +189.81%
Adicet Bio
Aug 10, 2023
Maintains: Buy
Price Target: $20 → $10
Current: $1.26
Upside: +693.65%
Jul 25, 2023
Initiates: Buy
Price Target: $16
Current: $1.55
Upside: +932.26%
Jul 3, 2023
Maintains: Buy
Price Target: $30 → $37
Current: $9.39
Upside: +294.04%
Jun 26, 2023
Maintains: Buy
Price Target: $34 → $35
Current: $19.28
Upside: +81.56%
Jun 13, 2023
Maintains: Buy
Price Target: $85 → $90
Current: $43.49
Upside: +106.94%
May 17, 2023
Initiates: Buy
Price Target: $31
Current: $17.54
Upside: +76.74%
Mar 28, 2023
Maintains: Buy
Price Target: $10 → $16
Current: $110.01
Upside: -85.91%
Dec 6, 2022
Downgrades: Neutral
Price Target: n/a
Current: $3.09
Upside: -
Nov 16, 2022
Maintains: Buy
Price Target: $21 → $10
Current: $5.86
Upside: +70.65%
May 18, 2021
Initiates: Buy
Price Target: $40
Current: $2.56
Upside: +1,465.56%